Mutations and Karyotype Predict Treatment Response in Myelodysplastic Syndromes

American Journal of Hematology - United States
doi 10.1002/ajh.25267
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Correction: Mutations in the DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes

Oncotarget
Oncology
2018English

IDH1 and IDH2 Mutations in Myelodysplastic Syndromes and Role in Disease Progression

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Myelodysplastic Syndromes

Cancer
Cancer ResearchOncology
2007English

Myelodysplastic Syndromes

2004English

Myelodysplastic Syndromes

2005English

Myelodysplastic Syndromes

2008English

Myelodysplastic Syndromes

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy